Looking in advance, the pharmaceutical source chain is poised for continued evolution and transformation driven by technological improvements, regulatory developments, and switching sector dynamics. A number of important trends and alternatives are very likely to form the future of the pharmaceutical offer chain:Pharmaceutical formulation would be